Full Name | See Inc. |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 2945 Preyde Blvd, Lansing, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013131580 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
See Inc. 2945 Preyde Blvd, Lansing, MI 48912-5624 Ph: (517) 485-5566 | See Inc. 2945 Preyde Blvd, Lansing, MI 48912-5624 Ph: (517) 485-5566 |
News Archive
A Mayo Clinic allergist and colleagues representing the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology announce they are revising the old classification of asthma patients by disease severity to determine treatment and moving to a new expectation for all asthma patients: excellent symptom control.
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
States, facing budget shortfalls, look for ways to save money on their Medicaid programs, including limiting hospital stays for enrollees. Wisconsin is holding hearings on plans to alter the programs there, and California is looking at restructuring the way health care is delivered to people who qualify for both Medicare and Medicaid. Meanwhile, Stateline reports that a number of states are using new technology to run their benefits programs.
The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing nearly $875,000 to help address a critical shortage of funding for pediatric cancer research.
The drug TEV-48125, shown to be effective for chronic migraine in a phase II trial, appears to work within 3 to 7 days of injection, researchers report.
› Verified 2 days ago
Jamie Marie Shay, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1515 Lake Lansing Rd Ste H, Lansing, MI 48912 Phone: 517-487-6511 Fax: 517-487-1331 | |
Dr. David Blair Whitney, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 340 E Edgewood Blvd, Lansing, MI 48911 Phone: 517-887-0015 Fax: 517-887-0233 | |
Paul R Kennedy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2117 E Grand River Ave, Lansing, MI 48912 Phone: 517-485-2213 Fax: 517-485-2220 | |
Lo Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave, Suite 110, Lansing, MI 48912 Phone: 517-364-5875 Fax: 517-364-5877 | |
Dr. Douglas Jack Ekholm, OD DOCTOR OF OPTOMET Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5417 W Saginaw Hwy, Care Of Wallace Opticians, Lansing, MI 48917 Phone: 517-323-4027 Fax: 517-323-1807 | |
Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6001 W Saginaw Hwy, Lansing, MI 48917 Phone: 517-886-2888 |